CorMedix Inc. Reports Q2 2026 Financial Results

What Happened

• CorMedix Inc. (ticker: CRMD) filed a Form 8-K dated August 13, 2026 (Item 2.02) to announce its results of operations and financial condition for the quarter ended June 30, 2026.
• The company furnished a press release reporting those quarterly results as Exhibit 99.1 to the 8-K. The report is signed by CEO Joseph Todisco.

Key Details

• Filing date: August 13, 2026 (Form 8-K, Item 2.02).
• Period covered: Quarter ended June 30, 2026.
• Disclosure delivery: Press release furnished as Exhibit 99.1.
• Signature: 8-K signed by Joseph Todisco, Chief Executive Officer.

Why It Matters

• Quarterly financial results provide updated information on CorMedix’s revenue, expenses, cash position and operating trends; these figures can affect investor decisions and the company’s stock price.
• The 8-K indicates the company has publicly released its Q2 2026 results; investors should read the Exhibit 99.1 press release for the specific revenue, profit/loss, and cash-balance figures and any management commentary or guidance.